The Future of Cancer Care: The Power of Precision with Dr. Michael LaRiviere

CC لمشاهدة المقابلة مع الترجمة العربية، اضغط على 🌐
في الفيديو ثم اختر اللغة العربية من قائمة الترجمات

Dr. Michael LaRiviere is an Assistant Professor of Radiation Oncology at the Perelman School of Medicine, University of Pennsylvania, and an Attending Radiation Oncologist at Penn Medicine. He is widely recognized for his expertise in proton therapy, total body irradiation (TBI), and advanced radiation techniques for both adult and pediatric patients.

With a deep commitment to translational research, Dr. LaRiviere’s work focuses on the interface between radiation therapy and the immune system, exploring how radiotherapy can enhance the effectiveness of immunotherapy and CAR-T cell therapy. His research is helping redefine how radiation is used in complex and relapsed cancers, particularly in hematologic malignancies.

Beyond his clinical and research roles, Dr. LaRiviere is a passionate educator and mentor. He actively contributes to resident training, multidisciplinary case discussions, and scientific publications aimed at improving cancer care outcomes. His scholarly work includes peer-reviewed studies on proton therapy for Hodgkin lymphoma, re-irradiation protocols, and novel radiation-immunology strategies, advancing the field of radiation oncology toward more precise, personalized, and patient-centered care.

Dr. LaRiviere earned his BA in Neuroscience from Amherst College, his MD from Emory University, and completed his residency in Radiation Oncology at the University of Pennsylvania, where he now serves on the clinical and academic faculty.

His approach blends the rigor of medical physics with the compassion of clinical medicine — a true example of how science and care converge for better patient outcomes.

🌐 Learn more about Dr. LaRiviere: pennmedicine.org/providers/michael-lariviere